中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2009年
z1期
10-11
,共2页
韦玉文%彭宇%周晓庭%陈浩%程洁曼
韋玉文%彭宇%週曉庭%陳浩%程潔曼
위옥문%팽우%주효정%진호%정길만
喉面罩%呼吸机,机械%正压呼吸
喉麵罩%呼吸機,機械%正壓呼吸
후면조%호흡궤,궤계%정압호흡
Laryngeal masks%Ventilators,mechanical%Positive-pressure respiration
目的 探讨PB840呼吸机无创通气模式(NIV)在ICU的应用范围、效果及安全性.方法 应用PB840呼吸机无创机械通气治疗了7例不同原因引起的呼吸衰竭病人,无创通气治疗4 h后,血气(PaO2,PaCO2和pH值)分析和临床症状改善情况分析.结果 治疗前后病人的PaO2,PaCO2和pH值相比较有显著性差异.治疗后血气指标改善显著(P<0.05),病人症状减轻或缓解;紫绀得到改善.但漏气情况仍是主要缺点,部分病人不能耐受时,需立即改为有创机械通气.结论 PB840呼吸机无创通气模式能改善呼衰病人的血气指标及临床症状,但对极危重病人应用要慎重.
目的 探討PB840呼吸機無創通氣模式(NIV)在ICU的應用範圍、效果及安全性.方法 應用PB840呼吸機無創機械通氣治療瞭7例不同原因引起的呼吸衰竭病人,無創通氣治療4 h後,血氣(PaO2,PaCO2和pH值)分析和臨床癥狀改善情況分析.結果 治療前後病人的PaO2,PaCO2和pH值相比較有顯著性差異.治療後血氣指標改善顯著(P<0.05),病人癥狀減輕或緩解;紫紺得到改善.但漏氣情況仍是主要缺點,部分病人不能耐受時,需立即改為有創機械通氣.結論 PB840呼吸機無創通氣模式能改善呼衰病人的血氣指標及臨床癥狀,但對極危重病人應用要慎重.
목적 탐토PB840호흡궤무창통기모식(NIV)재ICU적응용범위、효과급안전성.방법 응용PB840호흡궤무창궤계통기치료료7례불동원인인기적호흡쇠갈병인,무창통기치료4 h후,혈기(PaO2,PaCO2화pH치)분석화림상증상개선정황분석.결과 치료전후병인적PaO2,PaCO2화pH치상비교유현저성차이.치료후혈기지표개선현저(P<0.05),병인증상감경혹완해;자감득도개선.단루기정황잉시주요결점,부분병인불능내수시,수립즉개위유창궤계통기.결론 PB840호흡궤무창통기모식능개선호쇠병인적혈기지표급림상증상,단대겁위중병인응용요신중.
Objective PB840 ventilator to explore non-invasive ventilation (NIV) in the ICU of the application,efficacy and safety.Methods Application PB840 Ventilator-Non-invasive mechanical ventilation in the treatment of the seven cases of different causes of respiratory failure patients,non-invasive ventilation in the treatment of 4 h,the blood gas (PaO2,PaCO2 and pH value) analysis and analysis of clinical symptoms to improve the situation.Results Patient before and after treatment of PaO2,PaCO2 and pH compared to the value there is significant difference.Target to improve the blood after treatment significantly (P<0.05),reduce or alleviate the symptoms of sick;cyanosis improved.However,leakage is still a major disadvantage,some patients can not tolerate when there is need to immediately replace invasive mechanical ventilation.Conclusion PB840 ventilator mode non-invasive ventilation can improve the patient′s respiratory failure and clinical symptoms of blood-gas target,but most critically ill patients should be carefully applied.